Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells

Multi-targeted therapy of cancer by genistein

(2008) Sanjeev Banerjee et al.   CANCER LETTERS

MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells

(2008) S. Bafna et al.   CANCER RESEARCH

Induction of Cytoplasmic Accumulation of p53: A Mechanism for Low Levels of Arsenic Exposure to Predispose Cells for Malignant Transformation

(2008) Y. Huang et al.   CANCER RESEARCH

Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs

(2008) Michael C. Byrns et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Overexpression of Dihydrodiol Dehydrogenase as a Prognostic Marker in Resected Gastric Cancer Patients

(2008) Hung-Chi Chang et al.   DIGESTIVE DISEASES AND SCIENCES

Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2

(2008) Jingbo Pi et al.   FREE RADICAL BIOLOGY AND MEDICINE

The next innovation cycle in toxicogenomics: Environmental epigenetics

(2008) S REAMONBUETTNER et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells

(2008) J.-H. Park et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats

(2008) Takeki Uehara et al.   TOXICOLOGY

c-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse epidermal JB6 Cl41 cells

(2008) Dongyun Zhang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies

(2007) Michael C. Byrns et al.   BIOCHEMICAL PHARMACOLOGY

PI-3K/Akt Pathway-Dependent Cyclin D1 Expression Is Responsible for Arsenite-Induced Human Keratinocyte Transformation

(2007) Weiming Ouyang et al.   ENVIRONMENTAL HEALTH PERSPECTIVES